Auvelity, depression drug from Axsome Therapeutics, gets FDA approval

  • 📰 FOX26Houston
  • ⏱ Reading Time:
  • 45 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 53%

United States Headlines News

United States Latest News,United States Headlines

The biopharmaceutical company expects Auvelity to be commercially available in the U.S. in the fourth quarter of 2022.

, Axsome's therapy targets several neurotransmitters including glutamate and had succeeded in a late-stage trial in 2019. The long-awaited approval for the therapy comes after the agency found deficiencies in the company's application last year and extended its review of the drug.The World Health Organization says the global prevalence of anxiety and depression increased by 25% in the first year of the COVID-19 pandemic.

Loneliness, fear of infection, suffering and death for oneself and loved ones, grief following bereavement, and financial worries were all cited as factors leading to anxiety and depression. WHO also said depression is a common illness worldwide, with an estimated 3.8% of the population affected, including 5.0% among adults and 5.7% among adults older than 60 years. Approximately 280 million people in the world have depression.Symptoms of depression include depressed mood or a loss of pleasure or interest in activities, for most of the day, nearly every day, for at least two weeks, according to WHO.

If you or a loved one is feeling distressed, call the National Suicide Prevention Lifeline. The crisis center provides free and confidential emotional support 24 hours a day, 7 days a week to civilians and veterans. Call the National Suicide Prevention Lifeline at

Source: News Formal (newsformal.com)

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 448. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Auvelity, depression drug from Axsome Therapeutics, gets FDA approvalAxsome Therapeutics, Inc. announced the FDA has approved Auvelity, an oral drug used to treat major depressive disorder in adults quicker than other drugs on the market.
Source: FOX10Phoenix - 🏆 83. / 68 Read more »

Over-the-counter hearing aids may be available in the U.S. as soon as OctoberOver-the-counter hearing aids got FDA approval. Millions of Americans will have access to more affordable hearing aids by mid-October when the rule takes effect. Thanks, Trump!
Source: MarketWatch - 🏆 3. / 97 Read more »

My Daughter Says Her Life is Pointless: How can I help?Dear Care and Feeding: What can I say to my daughter to help her turn her life around?
Source: Slate - 🏆 716. / 51 Read more »

Abortion pill maker drops Mississippi lawsuit with national implications, but fight isn't overAbortion pill manufacturer GenBioPro voluntarily dismissed its lawsuit challenging Mississippi’s restrictions on medication abortion on Thursday, but the legal question it raised is unlikely to disappear.
Source: MSTODAYnews - 🏆 275. / 63 Read more »

Finland's prime minister takes drug test following leaked party video“In recent days, there have been quite grave public accusations that I was in a space where drugs were used, or that I myself used drugs,” Sanna Marin told reporters. She's got rhythm! Decriminalize All Drugs. Portugal Did It And So Can The U.S. Finland Should Be Like Portugal And Decriminalize All Drugs
Source: NBCNews - 🏆 10. / 86 Read more »

People Are Revealing Things That They've Begun To Like Less After Getting Older, And Yep, I'm Old“Getting older to reach adulthood was fun. Getting older to reach being a senior citizen is less fun.”
Source: BuzzFeed - 🏆 730. / 51 Read more »